Haemonetics signs CSL Plasma supply agreement, shares hit 52-week high
Haemonetics Corp. says it executed a non-exclusive supply agreement with CSL Plasma for NexSys PCS devices and Persona PLUS technology across CSL’s U.S. network, while leaving fiscal 2027 guidance unchanged.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.